Tag: pharmaceutical patents

item-image

Why Approved Generic Drugs Are Delayed: 2023-2025 Patent Case Analysis

Explore why FDA-approved generic drugs face multi-year delays. Analysis of patent thicketing, Paragraph IV certifications, and the 30-month stay from 2023-2025.

Edward Jepson-Randall, Apr, 20 2026